awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34470502-033A2AB0-89A8-4D29-B007-C1CCCA24A64C
Q34470502-033A2AB0-89A8-4D29-B007-C1CCCA24A64C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34470502-033A2AB0-89A8-4D29-B007-C1CCCA24A64C
The combination of milatuzumab, a humanized anti-CD74 antibody, and veltuzumab, a humanized anti-CD20 antibody, demonstrates activity in patients with relapsed and refractory B-cell non-Hodgkin lymphoma.
P2860
Q34470502-033A2AB0-89A8-4D29-B007-C1CCCA24A64C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34470502-033A2AB0-89A8-4D29-B007-C1CCCA24A64C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d78b55d131eb613a877b6e3d433ab21e7d1f9ab5
P2860
Combination anti-CD74 (milatuzumab) and anti-CD20 (rituximab) monoclonal antibody therapy has in vitro and in vivo activity in mantle cell lymphoma.